Goldman Sachs’s Humacyte HUMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.33M | Buy |
637,675
+121,977
| +24% | +$255K | ﹤0.01% | 3675 |
|
|
2025
Q1 | $879K | Sell |
515,698
-112,028
| -18% | -$191K | ﹤0.01% | 3899 |
|
|
2024
Q4 | $3.17M | Sell |
627,726
-204,784
| -25% | -$1.03M | ﹤0.01% | 3187 |
|
|
2024
Q3 | $4.53M | Buy |
832,510
+70,935
| +9% | +$386K | ﹤0.01% | 2821 |
|
|
2024
Q2 | $3.66M | Buy |
761,575
+662,723
| +670% | +$3.18M | ﹤0.01% | 2831 |
|
|
2024
Q1 | $307K | Sell |
98,852
-1,854
| -2% | -$5.77K | ﹤0.01% | 4187 |
|
|
2023
Q4 | $286K | Sell |
100,706
-31,824
| -24% | -$90.4K | ﹤0.01% | 4211 |
|
|
2023
Q3 | $388K | Buy |
132,530
+57,981
| +78% | +$170K | ﹤0.01% | 3985 |
|
|
2023
Q2 | $213K | Buy |
74,549
+11,666
| +19% | +$33.4K | ﹤0.01% | 4370 |
|
|
2023
Q1 | $194K | Buy |
62,883
+7,289
| +13% | +$22.5K | ﹤0.01% | 4530 |
|
|
2022
Q4 | $117K | Sell |
55,594
-16,164
| -23% | -$34.1K | ﹤0.01% | 4639 |
|
|
2022
Q3 | $234K | Buy |
71,758
+28,855
| +67% | +$94.1K | ﹤0.01% | 4653 |
|
|
2022
Q2 | $138K | Sell |
42,903
-53,063
| -55% | -$171K | ﹤0.01% | 5015 |
|
|
2022
Q1 | $678K | Buy |
95,966
+18,281
| +24% | +$129K | ﹤0.01% | 4389 |
|
|
2021
Q4 | $563K | Buy |
+77,685
| New | +$563K | ﹤0.01% | 4443 |
|